DIVIDEND ANNOUNCEMENT: Bristol Myers Squibb Co. (NYSE:BMY) on 06/15/2022 declared a dividend of $0.5400 per share

Bristol Myers Squibb Co. (NYSE:BMY) on 06/15/2022 declared a dividend of $ 0.5400 per share payable on August 01, 2022 to shareholders of record as of July 01, 2022.

Bristol Myers Squibb Co. (NYSE:BMY) has paid dividends since 1900, has a current dividend yield of 2.9641828537% and has increased its dividends for 12 successive years.

Bristol Myers Squibb Co.'s market cap is $ 155,144,893,680 and has a PE ratio of 0.00. The stock price closed yesterday at $ 72.87 and has a 52 week low/high of $ 53.22 and $ 78.61.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

For more information on Bristol Myers Squibb Co. click here.